Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Rivastigmine (sold under the trade name Exelon) is a acetylcholinesterase inhibitor used for the treatment of mild to moderate Alzheimer's disease and Parkinson's. The drug can be administered orally or via a transdermal patch; the latter form reduces the prevalence of side effects, which typically include nausea and vomiting.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Rivastigmine market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Rivastigmine market. Detailed analysis of key players, along with key growth strategies adopted by Rivastigmine industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Aurobindo Pharma
Sun Pharmaceutical
Orchid Healthcare
Cadila Pharmaceuticals
Dr Reddy's Laboratories
Novartis
Ajanta Pharma
Alembic Pharmaceuticals
MACLEODS
APOTEX
Teva
Alvogen
Mylan Pharmaceuticals
By Type:
Oral
Transdermal patch
By End-User:
Alzheimer's disease
Parkinson's
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Rivastigmine Market
-
1.3 Market Segment by Type
-
1.3.1 China Rivastigmine Market Size and Growth Rate of Oral from 2016 to 2027
-
1.3.2 China Rivastigmine Market Size and Growth Rate of Transdermal patch from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Rivastigmine Market Size and Growth Rate of Alzheimer's disease from 2016 to 2027
-
1.4.2 China Rivastigmine Market Size and Growth Rate of Parkinson's from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Rivastigmine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Rivastigmine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Rivastigmine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Rivastigmine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Rivastigmine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Rivastigmine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Rivastigmine Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Rivastigmine Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Rivastigmine by Major Types
-
3.4.1 Market Size and Growth Rate of Oral
-
3.4.2 Market Size and Growth Rate of Transdermal patch
4 Segmentation of Rivastigmine Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Rivastigmine by Major End-Users
-
4.4.1 Market Size and Growth Rate of Rivastigmine in Alzheimer's disease
-
4.4.2 Market Size and Growth Rate of Rivastigmine in Parkinson's
5 Market Analysis by Regions
-
5.1 China Rivastigmine Production Analysis by Regions
-
5.2 China Rivastigmine Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Rivastigmine Landscape Analysis
-
6.1 North China Rivastigmine Landscape Analysis by Major Types
-
6.2 North China Rivastigmine Landscape Analysis by Major End-Users
7 Central China Rivastigmine Landscape Analysis
-
7.1 Central China Rivastigmine Landscape Analysis by Major Types
-
7.2 Central China Rivastigmine Landscape Analysis by Major End-Users
8 South China Rivastigmine Landscape Analysis
-
8.1 South China Rivastigmine Landscape Analysis by Major Types
-
8.2 South China Rivastigmine Landscape Analysis by Major End-Users
9 East China Rivastigmine Landscape Analysis
-
9.1 East China Rivastigmine Landscape Analysis by Major Types
-
9.2 East China Rivastigmine Landscape Analysis by Major End-Users
10 Northeast China Rivastigmine Landscape Analysis
-
10.1 Northeast China Rivastigmine Landscape Analysis by Major Types
-
10.2 Northeast China Rivastigmine Landscape Analysis by Major End-Users
11 Southwest China Rivastigmine Landscape Analysis
-
11.1 Southwest China Rivastigmine Landscape Analysis by Major Types
-
11.2 Southwest China Rivastigmine Landscape Analysis by Major End-Users
12 Northwest China Rivastigmine Landscape Analysis
-
12.1 Northwest China Rivastigmine Landscape Analysis by Major Types
-
12.2 Northwest China Rivastigmine Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Aurobindo Pharma
-
13.1.1 Aurobindo Pharma Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Sun Pharmaceutical
-
13.2.1 Sun Pharmaceutical Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Orchid Healthcare
-
13.3.1 Orchid Healthcare Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Cadila Pharmaceuticals
-
13.4.1 Cadila Pharmaceuticals Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Dr Reddy's Laboratories
-
13.5.1 Dr Reddy's Laboratories Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Novartis
-
13.6.1 Novartis Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Ajanta Pharma
-
13.7.1 Ajanta Pharma Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Alembic Pharmaceuticals
-
13.8.1 Alembic Pharmaceuticals Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 MACLEODS
-
13.9.1 MACLEODS Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 APOTEX
-
13.10.1 APOTEX Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
-
13.11 Teva
-
13.11.1 Teva Company Profile and Recent Development
-
13.11.2 Market Performance
-
13.11.3 Product and Service Introduction
-
13.12 Alvogen
-
13.12.1 Alvogen Company Profile and Recent Development
-
13.12.2 Market Performance
-
13.12.3 Product and Service Introduction
-
13.13 Mylan Pharmaceuticals
-
13.13.1 Mylan Pharmaceuticals Company Profile and Recent Development
-
13.13.2 Market Performance
-
13.13.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Rivastigmine Market Size and Growth Rate of Oral from 2016 to 2027
-
Figure China Rivastigmine Market Size and Growth Rate of Transdermal patch from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Rivastigmine Market Size and Growth Rate of Alzheimer's disease from 2016 to 2027
-
Figure China Rivastigmine Market Size and Growth Rate of Parkinson's from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Rivastigmine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Rivastigmine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Rivastigmine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Rivastigmine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Rivastigmine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Rivastigmine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Rivastigmine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Rivastigmine Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Rivastigmine
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Rivastigmine by Different Types from 2016 to 2027
-
Table Consumption Share of Rivastigmine by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Oral
-
Figure Market Size and Growth Rate of Transdermal patch
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Rivastigmine by Different End-Users from 2016 to 2027
-
Table Consumption Share of Rivastigmine by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Alzheimer's disease
-
Figure Market Size and Growth Rate of Parkinson's
-
Table China Rivastigmine Production by Regions
-
Table China Rivastigmine Production Share by Regions
-
Figure China Rivastigmine Production Share by Regions in 2016
-
Figure China Rivastigmine Production Share by Regions in 2021
-
Figure China Rivastigmine Production Share by Regions in 2027
-
Table China Rivastigmine Consumption by Regions
-
Table China Rivastigmine Consumption Share by Regions
-
Figure China Rivastigmine Consumption Share by Regions in 2016
-
Figure China Rivastigmine Consumption Share by Regions in 2021
-
Figure China Rivastigmine Consumption Share by Regions in 2027
-
Table North China Rivastigmine Consumption by Types from 2016 to 2027
-
Table North China Rivastigmine Consumption Share by Types from 2016 to 2027
-
Figure North China Rivastigmine Consumption Share by Types in 2016
-
Figure North China Rivastigmine Consumption Share by Types in 2021
-
Figure North China Rivastigmine Consumption Share by Types in 2027
-
Table North China Rivastigmine Consumption by End-Users from 2016 to 2027
-
Table North China Rivastigmine Consumption Share by End-Users from 2016 to 2027
-
Figure North China Rivastigmine Consumption Share by End-Users in 2016
-
Figure North China Rivastigmine Consumption Share by End-Users in 2021
-
Figure North China Rivastigmine Consumption Share by End-Users in 2027
-
Table Central China Rivastigmine Consumption by Types from 2016 to 2027
-
Table Central China Rivastigmine Consumption Share by Types from 2016 to 2027
-
Figure Central China Rivastigmine Consumption Share by Types in 2016
-
Figure Central China Rivastigmine Consumption Share by Types in 2021
-
Figure Central China Rivastigmine Consumption Share by Types in 2027
-
Table Central China Rivastigmine Consumption by End-Users from 2016 to 2027
-
Table Central China Rivastigmine Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Rivastigmine Consumption Share by End-Users in 2016
-
Figure Central China Rivastigmine Consumption Share by End-Users in 2021
-
Figure Central China Rivastigmine Consumption Share by End-Users in 2027
-
Table South China Rivastigmine Consumption by Types from 2016 to 2027
-
Table South China Rivastigmine Consumption Share by Types from 2016 to 2027
-
Figure South China Rivastigmine Consumption Share by Types in 2016
-
Figure South China Rivastigmine Consumption Share by Types in 2021
-
Figure South China Rivastigmine Consumption Share by Types in 2027
-
Table South China Rivastigmine Consumption by End-Users from 2016 to 2027
-
Table South China Rivastigmine Consumption Share by End-Users from 2016 to 2027
-
Figure South China Rivastigmine Consumption Share by End-Users in 2016
-
Figure South China Rivastigmine Consumption Share by End-Users in 2021
-
Figure South China Rivastigmine Consumption Share by End-Users in 2027
-
Table East China Rivastigmine Consumption by Types from 2016 to 2027
-
Table East China Rivastigmine Consumption Share by Types from 2016 to 2027
-
Figure East China Rivastigmine Consumption Share by Types in 2016
-
Figure East China Rivastigmine Consumption Share by Types in 2021
-
Figure East China Rivastigmine Consumption Share by Types in 2027
-
Table East China Rivastigmine Consumption by End-Users from 2016 to 2027
-
Table East China Rivastigmine Consumption Share by End-Users from 2016 to 2027
-
Figure East China Rivastigmine Consumption Share by End-Users in 2016
-
Figure East China Rivastigmine Consumption Share by End-Users in 2021
-
Figure East China Rivastigmine Consumption Share by End-Users in 2027
-
Table Northeast China Rivastigmine Consumption by Types from 2016 to 2027
-
Table Northeast China Rivastigmine Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Rivastigmine Consumption Share by Types in 2016
-
Figure Northeast China Rivastigmine Consumption Share by Types in 2021
-
Figure Northeast China Rivastigmine Consumption Share by Types in 2027
-
Table Northeast China Rivastigmine Consumption by End-Users from 2016 to 2027
-
Table Northeast China Rivastigmine Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Rivastigmine Consumption Share by End-Users in 2016
-
Figure Northeast China Rivastigmine Consumption Share by End-Users in 2021
-
Figure Northeast China Rivastigmine Consumption Share by End-Users in 2027
-
Table Southwest China Rivastigmine Consumption by Types from 2016 to 2027
-
Table Southwest China Rivastigmine Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Rivastigmine Consumption Share by Types in 2016
-
Figure Southwest China Rivastigmine Consumption Share by Types in 2021
-
Figure Southwest China Rivastigmine Consumption Share by Types in 2027
-
Table Southwest China Rivastigmine Consumption by End-Users from 2016 to 2027
-
Table Southwest China Rivastigmine Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Rivastigmine Consumption Share by End-Users in 2016
-
Figure Southwest China Rivastigmine Consumption Share by End-Users in 2021
-
Figure Southwest China Rivastigmine Consumption Share by End-Users in 2027
-
Table Northwest China Rivastigmine Consumption by Types from 2016 to 2027
-
Table Northwest China Rivastigmine Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Rivastigmine Consumption Share by Types in 2016
-
Figure Northwest China Rivastigmine Consumption Share by Types in 2021
-
Figure Northwest China Rivastigmine Consumption Share by Types in 2027
-
Table Northwest China Rivastigmine Consumption by End-Users from 2016 to 2027
-
Table Northwest China Rivastigmine Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Rivastigmine Consumption Share by End-Users in 2016
-
Figure Northwest China Rivastigmine Consumption Share by End-Users in 2021
-
Figure Northwest China Rivastigmine Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Aurobindo Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aurobindo Pharma
-
Figure Sales and Growth Rate Analysis of Aurobindo Pharma
-
Figure Revenue and Market Share Analysis of Aurobindo Pharma
-
Table Product and Service Introduction of Aurobindo Pharma
-
Table Company Profile and Development Status of Sun Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Sun Pharmaceutical
-
Figure Revenue and Market Share Analysis of Sun Pharmaceutical
-
Table Product and Service Introduction of Sun Pharmaceutical
-
Table Company Profile and Development Status of Orchid Healthcare
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Orchid Healthcare
-
Figure Sales and Growth Rate Analysis of Orchid Healthcare
-
Figure Revenue and Market Share Analysis of Orchid Healthcare
-
Table Product and Service Introduction of Orchid Healthcare
-
Table Company Profile and Development Status of Cadila Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cadila Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Cadila Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Cadila Pharmaceuticals
-
Table Product and Service Introduction of Cadila Pharmaceuticals
-
Table Company Profile and Development Status of Dr Reddy's Laboratories
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dr Reddy's Laboratories
-
Figure Sales and Growth Rate Analysis of Dr Reddy's Laboratories
-
Figure Revenue and Market Share Analysis of Dr Reddy's Laboratories
-
Table Product and Service Introduction of Dr Reddy's Laboratories
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Ajanta Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ajanta Pharma
-
Figure Sales and Growth Rate Analysis of Ajanta Pharma
-
Figure Revenue and Market Share Analysis of Ajanta Pharma
-
Table Product and Service Introduction of Ajanta Pharma
-
Table Company Profile and Development Status of Alembic Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alembic Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Alembic Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Alembic Pharmaceuticals
-
Table Product and Service Introduction of Alembic Pharmaceuticals
-
Table Company Profile and Development Status of MACLEODS
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of MACLEODS
-
Figure Sales and Growth Rate Analysis of MACLEODS
-
Figure Revenue and Market Share Analysis of MACLEODS
-
Table Product and Service Introduction of MACLEODS
-
Table Company Profile and Development Status of APOTEX
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of APOTEX
-
Figure Sales and Growth Rate Analysis of APOTEX
-
Figure Revenue and Market Share Analysis of APOTEX
-
Table Product and Service Introduction of APOTEX
-
Table Company Profile and Development Status of Teva
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva
-
Figure Sales and Growth Rate Analysis of Teva
-
Figure Revenue and Market Share Analysis of Teva
-
Table Product and Service Introduction of Teva
-
Table Company Profile and Development Status of Alvogen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alvogen
-
Figure Sales and Growth Rate Analysis of Alvogen
-
Figure Revenue and Market Share Analysis of Alvogen
-
Table Product and Service Introduction of Alvogen
-
Table Company Profile and Development Status of Mylan Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Mylan Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Mylan Pharmaceuticals
-
Table Product and Service Introduction of Mylan Pharmaceuticals
-
